Anaerobic pulmonary infections in children

Itzhak Brook1

  • 1Department of Pediatrics, Georgetown University School of Medicine, Washington, DC, USA. ib6@georgetown.edu

Pediatric Emergency Care
|December 16, 2004
PubMed

Insights

Anaerobic bacteria from the mouth cause serious lung infections in children, often with other bacteria. Treatment requires antibiotics targeting both anaerobic and aerobic pathogens for effective recovery.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Pulmonology

Background:

  • Pulmonary infections involving anaerobic bacteria are typically observed in pediatric patients with a history of aspiration.
  • The oropharyngeal region serves as the primary reservoir for anaerobic bacteria, significantly outnumbering aerobic and facultative organisms.
  • Common lower respiratory tract infections associated with anaerobic bacteria include aspiration pneumonia, lung abscess, and empyema.

Purpose of the Study:

  • To review the epidemiology and microbiology of anaerobic pulmonary infections in children.
  • To highlight the common clinical presentations and causative anaerobic pathogens.
  • To emphasize the principles of antimicrobial management for these mixed infections.

Main Methods:

  • Review of literature on anaerobic pulmonary infections in pediatric populations.
  • Identification of predominant anaerobic bacterial species isolated from lower respiratory tract infections.
  • Discussion of current antimicrobial strategies.

Main Results:

  • Anaerobic pulmonary infections predominantly affect children with aspiration risk factors.
  • The oropharyngeal flora is the main source, with anaerobes outnumbering aerobes.
  • Key isolated anaerobes include Peptostreptococcus, Fusobacterium, Prevotella, Porphyromonas, and Bacteroides fragilis group.
  • These infections often present as polymicrobial, involving both anaerobic and aerobic bacteria.

Conclusions:

  • Anaerobic bacteria play a significant role in pediatric lower respiratory tract infections, particularly in aspirating children.
  • Effective management necessitates antimicrobial agents with broad-spectrum activity against both anaerobic and aerobic pathogens.
  • Understanding the source and common pathogens is crucial for appropriate treatment and improved patient outcomes.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...